Interscalene Nerve Block: Comprehensive Guide to Anatomy, Technique, & Complications

Introduction and Epidemiology

The interscalene nerve block is a foundational regional anesthetic technique widely employed in orthopedic surgery for procedures involving the shoulder and proximal humerus. It provides profound analgesia and anesthesia to the C5 through C7 dermatomes, encompassing the shoulder girdle and often extending to the lateral arm, making it invaluable for both intraoperative management and postoperative pain control. Its efficacy in reducing opioid consumption, minimizing opioid related side effects, and facilitating earlier rehabilitation has cemented its role in enhanced recovery after surgery protocols for shoulder procedures.

Historically, interscalene nerve blocks were performed using paresthesia or nerve stimulator techniques based on surface landmarks. However, the advent and widespread adoption of ultrasound guidance have revolutionized the safety and precision of this block. Ultrasound allows for real time visualization of the brachial plexus roots and trunks within the interscalene groove, as well as surrounding critical structures such as the phrenic nerve, vertebral artery, and pleura. This has led to a significant reduction in the incidence of severe complications, although minor and expected physiologic side effects remain prevalent.

Epidemiologically, the interscalene nerve block is one of the most frequently performed regional blocks in upper extremity orthopedic surgery. Success rates for achieving adequate surgical anesthesia and analgesia are consistently high, often exceeding 95 percent with ultrasound guidance. While highly effective, the anatomical proximity of several vital structures to the brachial plexus in the interscalene region means that collateral spread of local anesthetic and unintended blockade are common. A thorough understanding of these expected side effects, as well as rarer, more serious complications, is paramount for safe and effective practice by orthopedic surgeons, anesthesiologists, and surgical trainees.

Surgical Anatomy and Biomechanics

A comprehensive understanding of the anatomy of the neck and brachial plexus is critical for safe and effective interscalene nerve block performance. The brachial plexus is formed by the ventral rami of spinal nerves C5 through T1, with occasional contributions from C4 and T2. These roots emerge between the anterior and middle scalene muscles, forming the interscalene groove.

Key Anatomical Structures

The scalene musculature forms the primary landmark for sonographic identification. The anterior scalene originates from the transverse processes of C3 through C6 and inserts onto the first rib. Its anterior surface is traversed by the phrenic nerve, a critical relationship when considering local anesthetic spread. The middle scalene originates from the transverse processes of C2 through C7 and inserts onto the first rib, posterior to the anterior scalene. The interscalene groove is the fascial plane located between the anterior and middle scalene muscles, through which the roots and trunks of the brachial plexus pass.

At the level of the interscalene groove, typically corresponding to the C6 cricoid level, the brachial plexus consists primarily of the roots and their early amalgamation into superior, middle, and inferior trunks. Ultrasound visualization reveals hypoechoic, round or ovoid structures arranged in a vertical alignment within the interscalene groove, often described as a stoplight appearance. These typically correspond to the C5, C6, and C7 roots from superior to inferior. The primary targets for this block are the C5 and C6 roots, which predominantly innervate the glenohumeral joint, acromioclavicular joint, and surrounding rotator cuff musculature.

Associated Neural Structures

Several critical neural structures reside in close proximity to the interscalene groove and are susceptible to inadvertent blockade. The phrenic nerve arises from C3 through C5 and descends obliquely across the anterior surface of the anterior scalene muscle beneath the prevertebral fascia. Due to this proximity, anterior spread of local anesthetic frequently results in hemidiaphragmatic paresis.

The dorsal scapular nerve, originating primarily from C5, frequently pierces the middle scalene muscle directly posterior to the brachial plexus. The long thoracic nerve, arising from the C5 through C7 roots, typically courses through or posterior to the middle scalene muscle. Both nerves can be visualized sonographically and must be avoided during needle advancement to prevent isolated motor neuropathies. Furthermore, the sympathetic chain, specifically the stellate ganglion, lies medial to the scalene musculature over the longus colli muscle. Medial tracking of local anesthetic along the prevertebral fascia can result in Horner syndrome.

Critical Vascular Landmarks

Vascular anatomy in the cervical region is highly variable and dense. The carotid artery and internal jugular vein lie medial to the anterior scalene muscle. The vertebral artery typically ascends through the transverse foramen of C6, known as Chassaignac tubercle, but anatomical variants where it enters at C5 or C4 exist. The transverse cervical artery and suprascapular artery often cross the interscalene groove superficially and must be identified using color Doppler prior to needle insertion to avoid inadvertent intravascular injection or hematoma formation.

Fascial Planes and Anesthetic Spread

The biomechanics of the interscalene nerve block rely on the deposition of local anesthetic within the prevertebral fascial envelope surrounding the brachial plexus. The goal is to hydrodissect this fascial plane, allowing the anesthetic to bathe the targeted neural structures. The investing fascia limits superficial spread, directing the volume longitudinally along the nerve roots. However, excessive volume or high injection pressures can force anesthetic medially toward the epidural space or anteriorly toward the phrenic nerve. Modern techniques advocate for targeted, low volume injections to minimize this collateral spread while maintaining analgesic efficacy.

Indications and Contraindications

The interscalene nerve block is indicated for procedures involving the distal clavicle, shoulder joint, and proximal humerus. It is particularly valuable in major open and arthroscopic shoulder surgeries where severe postoperative pain is anticipated. Because the block reliably covers the C5 and C6 dermatomes and myotomes, it provides excellent coverage for the shoulder but is insufficient for surgeries of the distal humerus, forearm, or hand, as the C8 and T1 roots are frequently spared.

Appropriate Clinical Scenarios

For orthopedic procedures, the interscalene block can be utilized as the sole anesthetic technique for superficial procedures, or more commonly, as an analgesic adjunct to general anesthesia. In the setting of total shoulder arthroplasty, rotator cuff repair, and proximal humerus fracture fixation, the block significantly reduces volatile anesthetic requirements, blunts the surgical stress response, and facilitates rapid emergence.

Absolute and Relative Contraindications

Patient selection is paramount to minimize morbidity. Absolute contraindications include patient refusal, active infection at the injection site, and documented allergy to amide local anesthetics.

Relative contraindications require careful risk to benefit analysis. The most critical relative contraindication is severe pulmonary pathology. Because interscalene blocks frequently cause ipsilateral phrenic nerve paresis, patients with severe chronic obstructive pulmonary disease, contralateral phrenic nerve palsy, or marginal pulmonary reserve may experience acute respiratory failure. Pre existing neurologic deficits in the operative limb, such as cervical radiculopathy or peripheral neuropathy, are also relative contraindications due to the risk of compounding the deficit or confusing postoperative neurological assessments. Finally, coagulopathy or therapeutic anticoagulation must be managed according to established regional anesthesia guidelines to prevent compressive hematoma.

Pre Operative Planning and Patient Positioning

Meticulous preparation is required to execute an ultrasound guided interscalene nerve block safely. This involves appropriate equipment selection, pharmacologic preparation, and ergonomic patient positioning to optimize sonographic visualization and needle control.

Equipment and Pharmacologic Selection

A high frequency linear array ultrasound transducer, typically 10 to 15 Megahertz, is required to provide the high spatial resolution necessary for superficial cervical anatomy. The machine should be positioned on the contralateral side of the patient, allowing the operator to maintain an uninterrupted line of sight aligning the needle, transducer, and screen.

Pharmacologic selection depends on the desired duration of analgesia. For prolonged postoperative pain control, long acting amide local anesthetics such as bupivacaine 0.5 percent or ropivacaine 0.5 percent are standard. Historically, volumes of 20 to 30 milliliters were used; however, contemporary evidence strongly supports low volume techniques utilizing 5 to 10 milliliters. This reduction in volume provides equivalent analgesia while significantly decreasing the incidence of phrenic nerve blockade. Adjuvants such as perineural dexamethasone, typically 1 to 2 milligrams, or intravenous dexamethasone, can be utilized to prolong the duration of the sensory block without increasing the risk of neurotoxicity.

Patient Positioning and Ergonomics

The patient is typically positioned supine or in a semi lateral decubitus position. The head is turned approximately 30 to 45 degrees away from the operative side. Excessive rotation should be avoided as it can distort the anatomy, flattening the interscalene groove and making visualization difficult. The ipsilateral arm should rest comfortably at the patient's side, with slight downward traction applied to the shoulder to depress the clavicle and open the supraclavicular space.

The operator typically stands at the head of the bed or on the ipsilateral side, depending on handedness and the chosen needle trajectory. Strict aseptic technique is mandatory, including a sterile ultrasound probe cover, sterile ultrasound gel, and chlorhexidine skin preparation.

Detailed Surgical Approach and Technique

The sonographic dissection and approach to the interscalene brachial plexus require a systematic method to identify the neural targets while avoiding vascular and fascial pitfalls. The procedure can be conceptualized in three phases: sonographic topography, needle trajectory, and injection dynamics.

Ultrasound Topography and Image Acquisition

Two primary sonographic techniques are utilized to identify the interscalene brachial plexus. The direct approach involves placing the transducer transversely at the level of the cricoid cartilage. The operator identifies the carotid artery and internal jugular vein medially, then scans laterally to identify the anterior scalene muscle. The interscalene groove is located immediately lateral to the anterior scalene, containing the hypoechoic nerve roots.

Alternatively, the trace back technique is highly reliable. The transducer is placed in the supraclavicular fossa to identify the subclavian artery and the clustered brachial plexus trunks. The transducer is then slowly translated cephalad along the neck. The operator observes the subclavian artery diving deep while the brachial plexus moves superficially and separates into distinct roots as it enters the interscalene groove between the anterior and middle scalene muscles. Color Doppler must be applied over the target area to identify any traversing vessels, particularly the transverse cervical artery.

Needle Trajectory and Fascial Penetration

An in plane needle approach is strongly recommended to allow continuous visualization of the needle shaft and tip. A 50 millimeter, short bevel echogenic block needle is introduced from a lateral to medial direction, passing through the middle scalene muscle.

The needle tip is advanced toward the interscalene groove. The critical anatomical barrier is the prevertebral fascia enveloping the brachial plexus. As the needle contacts this fascia, a distinct pop or loss of resistance is often appreciated sonographically as the fascia tents and then yields. The target destination for the needle tip is the connective tissue space immediately adjacent to the C5 and C6 roots. The needle must remain extra epineural; intraneural placement is strictly avoided to prevent fascicular injury.

Injection Dynamics and Target Validation

Once the needle tip is positioned optimally, careful aspiration is performed to rule out intravascular placement. An initial test dose of 1 to 2 milliliters of local anesthetic or saline is injected. The operator must observe for anechoic fluid spread separating the nerve roots from the surrounding musculature, known as hydrodissection.

If high injection pressure is encountered, or if the nerve root swells upon injection, the needle is likely intraneural and must be withdrawn immediately. Aspiration and injection should be performed in small aliquots of 3 to 5 milliliters. For targeted shoulder analgesia, depositing 5 to 10 milliliters of local anesthetic between the C5 and C6 roots is sufficient. The fluid should spread longitudinally within the fascial sheath, creating a halo effect around the targeted neural structures.

Complications and Management

While ultrasound guidance has maximized the safety profile of the interscalene nerve block, the dense anatomical real estate of the cervical region makes collateral blockade and complications a persistent clinical reality. Complications can be categorized into expected physiologic side effects due to collateral spread, and severe procedural complications.

Expected Physiologic Collateral Blockade

The most common side effect is phrenic nerve blockade, leading to ipsilateral hemidiaphragmatic paresis. With traditional high volume techniques, the incidence approaches 100 percent. While often asymptomatic in healthy patients, it can cause dyspnea and hypoxemia in patients with compromised pulmonary function. Low volume techniques and targeted injections posterior to the C5 root have reduced this incidence, but it remains a significant consideration.

Horner syndrome, characterized by ipsilateral ptosis, miosis, and anhidrosis, occurs due to the medial spread of local anesthetic to the stellate ganglion. It is benign and self limiting. Similarly, blockade of the recurrent laryngeal nerve can cause hoarseness and dysphagia. Patients should be reassured that these are temporary effects that will resolve as the local anesthetic metabolizes.

Severe Procedural Complications

Severe complications, while rare, carry significant morbidity. Intraneural injection can lead to mechanical fascicular disruption or chemical neurotoxicity, resulting in prolonged or permanent neuropathy. Pneumothorax is a risk if the needle is advanced too deeply and caudally, piercing the apical pleura.

Inadvertent neuraxial spread is a catastrophic complication. Medial needle advancement through the intervertebral foramen can result in epidural, subdural, or subarachnoid injection. This presents as a total spinal anesthetic, characterized by rapid onset of profound hypotension, bradycardia, respiratory arrest, and loss of consciousness, requiring immediate advanced airway management and hemodynamic support.

Local Anesthetic Systemic Toxicity

Local Anesthetic Systemic Toxicity is a life threatening complication resulting from inadvertent intravascular injection, most commonly into the vertebral artery or external jugular vein, or from rapid systemic absorption. Symptoms progress from perioral numbness, tinnitus, and metallic taste to seizures, arrhythmias, and cardiovascular collapse.

Management of Local Anesthetic Systemic Toxicity requires immediate cessation of the injection, airway management, seizure suppression with benzodiazepines, and the prompt administration of 20 percent lipid emulsion therapy. The standard protocol dictates an initial bolus of 1.5 milliliters per kilogram of lean body mass, followed by a continuous infusion.

Post Operative Rehabilitation Protocols

The profound analgesia provided by an interscalene nerve block significantly alters the immediate postoperative rehabilitation trajectory. While it enables early mobilization and improves patient satisfaction, specific protocols must be in place to manage the insensate limb and prepare for block resolution.

Rebound Pain Mitigation Strategies

Rebound pain is a well documented phenomenon following the resolution of a single shot interscalene block, characterized by a rapid escalation of severe pain as the local anesthetic wears off, typically 12 to 24 hours postoperatively. To mitigate this, a robust multimodal oral analgesic regimen must be initiated while the block is still active.

Orthopedic surgeons must ensure that patients receive scheduled acetaminophen, non steroidal anti inflammatory drugs, and oral opioids prior to the anticipated offset of the block. Patient education regarding the timing of the block offset and the necessity of taking oral analgesics proactively is a critical component of the enhanced recovery pathway.

Motor Blockade and Limb Protection

The interscalene block produces a dense motor block of the shoulder and arm. The insensate and flaccid limb is highly susceptible to traction injuries, positioning neuropraxias, and inadvertent trauma. The operative arm must be securely immobilized in a sling or shoulder immobilizer immediately postoperatively.

Physical therapy protocols in the immediate 24 hour postoperative period should focus on passive range of motion performed by the therapist or utilizing the contralateral limb, strictly avoiding active contraction of the blocked musculature. Weight bearing and active mobilization are contraindicated until full sensory and motor function have returned to baseline.

Summary of Key Literature and Guidelines

The clinical application of the interscalene nerve block is governed by evolving literature and consensus guidelines aimed at maximizing efficacy while minimizing complications. Orthopedic surgeons and anesthesiologists must remain current with these recommendations to optimize patient care.

Enhanced Recovery After Surgery Recommendations

The Enhanced Recovery After Surgery Society and the PROSPECT working group strongly recommend the use of regional anesthesia, specifically the interscalene nerve block, as a first line analgesic modality for major shoulder surgery. The literature demonstrates that compared to systemic opioids alone, interscalene blocks significantly reduce postoperative pain scores, decrease opioid consumption, lower the incidence of postoperative nausea and vomiting, and shorten post anesthesia care unit length of stay.

For continuous analgesia, perineural catheter techniques have been validated in the literature, though they are increasingly being replaced by single shot techniques utilizing liposomal bupivacaine or perineural dexamethasone due to the logistical challenges and infection risks associated with indwelling catheters.

Phrenic Nerve Sparing Techniques Literature

A massive paradigm shift in the literature over the last decade has focused on phrenic nerve sparing techniques. High quality randomized controlled trials have demonstrated that reducing the local anesthetic volume from 20 milliliters to 5 milliliters provides non inferior analgesia while significantly reducing the incidence of complete hemidiaphragmatic paresis.

Furthermore, anatomical studies and clinical trials have evaluated extra fascial injection techniques, where the local anesthetic is deposited lateral to the middle scalene muscle or further away from the C5 root. Additionally, targeting the superior trunk further distally in the supraclavicular region has been shown to preserve pulmonary function more effectively than traditional proximal interscalene approaches, while maintaining excellent surgical analgesia for the shoulder. These advancements highlight the continuous evolution of regional anesthesia techniques in orthopedic surgery, driven by a commitment to patient safety and optimized functional outcomes.